Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Expansion of the phenotypic spectrum of de novo missense variants in kinesin family member 1A (KIF1A)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A single c.1715G>C calpain 3 gene variant causes dominant calpainopathy with loss of calpain 3 expression and activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. From genotype to phenotype: Early prediction of disease severity in argininosuccinic aciduria

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Multigenic truncation of the semaphorin-plexin pathway by a germline chromothriptic rearrangement associated with Moebius syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Direct to consumer genetic testing in Denmark-public knowledge, use, and attitudes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genetisk screening af adopterede raske individer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Genetisk screening af kommende forældre

    Research output: Contribution to journalJournal articleResearchpeer-review

  • kConFab investigators
View graph of relations

The multifactorial likelihood analysis method has demonstrated utility for quantitative assessment of variant pathogenicity for multiple cancer syndrome genes. Independent data types currently incorporated in the model for assessing BRCA1 and BRCA2 variants include clinically calibrated prior probability of pathogenicity based on variant location and bioinformatic prediction of variant effect, co-segregation, family cancer history profile, co-occurrence with a pathogenic variant in the same gene, breast tumor pathology, and case-control information. Research and clinical data for multifactorial likelihood analysis were collated for 1,395 BRCA1/2 predominantly intronic and missense variants, enabling classification based on posterior probability of pathogenicity for 734 variants: 447 variants were classified as (likely) benign, and 94 as (likely) pathogenic; and 248 classifications were new or considerably altered relative to ClinVar submissions. Classifications were compared with information not yet included in the likelihood model, and evidence strengths aligned to those recommended for ACMG/AMP classification codes. Altered mRNA splicing or function relative to known nonpathogenic variant controls were moderately to strongly predictive of variant pathogenicity. Variant absence in population datasets provided supporting evidence for variant pathogenicity. These findings have direct relevance for BRCA1 and BRCA2 variant evaluation, and justify the need for gene-specific calibration of evidence types used for variant classification.

Original languageEnglish
JournalHuman Mutation
Volume40
Issue number9
Pages (from-to)1557-1578
Number of pages22
ISSN1059-7794
DOIs
Publication statusPublished - Sep 2019

ID: 58958385